Treatment of progressive myopia with 0.01% Atropine in children and adolescents: an Italian 4-year follow-up study.
0.01% atropine was effective in slowing the progression of myopia in the treated group vs. control one. The clinical effect was noticeable already from the first control, and continued for all the observation period. The results of this study agree with those already reported in literature, and confirm the validity of this treatment.
Authors
- M Salducci (ORCID: https://orcid.org/0000-0003-4270-3022)
- Andrew F. Trofa
- Serena Palmieri (ORCID: https://orcid.org/0000-0002-1137-461X)
- Nicola Galantuomo
- Miguel Rechichi (ORCID: https://orcid.org/0000-0002-1016-2535)
- Riccardo E. Giunta (ORCID: https://orcid.org/0009-0007-7421-1213)
- Marzio Di Meglio
- G Galantuomo
- L Pacente
Institutions
- Centro Polispecialistico Mediterraneo
Publication Details
- Journal
- PubMed
- Published
- 2024-10-14
- DOI
- https://doi.org/10.7417/ct.2024.5129
- Citations
- 2
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77